Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform

PURPOSE: Pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in early breast cancer (EBC) is largely dependent on breast cancer subtype, but no clinical-grade model exists to predict response and guide selection of treatment. A biophysical simulation of response to NAC has the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Frederick M., He, Gong, Peterson, Joseph R., Pfeiffer, J. R., Earnest, Tyler, Pearson, Alexander T., Abe, Hiroyuki, Cole, John A., Nanda, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550684/
https://www.ncbi.nlm.nih.gov/pubmed/36063220
http://dx.doi.org/10.1007/s10549-022-06722-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550684/
https://www.ncbi.nlm.nih.gov/pubmed/36063220
http://dx.doi.org/10.1007/s10549-022-06722-0

Ejemplares similares